Injective (INJ) Building Strength: Is the Bullish Path Unfolding?

TheNewsCryptoPublished on 2026-02-19Last updated on 2026-02-19

Abstract

Amidst a fearful crypto market, Injective (INJ) stands out with a 3.7% price increase over 24 hours. After opening at a low of $2.96, it reached a high of $3.62 and is currently trading around $3.22. Trading volume surged over 525% to $191.43 million. Technical analysis suggests a potential climb towards the $3.32 resistance level, with further upside possible to $3.43 if bullish pressure continues. Support is seen near $3.12, with a break lower potentially leading to a drop to $3.01. Indicators present a mixed but cautiously optimistic picture: the MACD is in bullish territory but momentum is weak, the CMF shows selling pressure at -0.16, while the RSI at 58.50 and positive Bull Bear Power suggest buyers are currently in control.

With extreme fear hanging in the crypto market, the bears are gaining more power day by day. The total market cap is resting at $2.3 trillion, after a modest loss. Bitcoin (BTC) and Ethereum (ETH) are the largest dominant assets, which attempt to escape the bear market. Among the altcoins, Injective (INJ) has registered a 3.7% spike over the past 24 hours.

The asset opened the day trading on the downside, at a low range of $2.96. As the INJ market sees a bullish ray, the price rose to a high of $3.62. As per CMC data, at the time of writing, Injective traded at the $3.22 level. Concurrently, the daily trading volume has skyrocketed by over 525% and reached the $191.43 million mark.

Zooming in on the 4-hour trading pattern of Injective, it displays the early stage of the uptrend. The price might climb toward the $3.32 resistance level. With the upside pressure continuing to intensify, the bulls could push the price above $3.43. On the downside, assuming the asset’s momentum turned bearish, the price could immediately fall and find support at around $3.12. If Injective fails to hold this level, the bears might strengthen and take the price to the $3.01 zone or even lower.

Injective’s Technical Setup Signals a Bullish Shift

When both the Moving Average Convergence Divergence (MACD) line and signal lines of Injective are found above the zero line, indicating that the trend is bullish. As the signal line is slightly above zero, the positive momentum is weak. It needs to build more strength to confirm the broader uptrend.

In addition, the Chaikin Money Flow (CMF) indicator, which assesses the capital flow, has a value of -0.16, suggesting moderate selling pressure in the INJ market. Since it is clearly below the zero mark, the money outflow is stronger, and it is likely reflecting distribution rather than accumulation.

Injective’s active market sentiment is mild to moderate bullish sentiment, with the Relative Strength Index (RSI) at 58.50. It is above the neutral level and has enough room to move higher before hitting the overbought zone. Besides, the Bull Bear Power (BBP) reading of INJ at 0.131 implies solid bullish pressure. Notably, the buyers are in control, with the current momentum favouring the bulls and strengthening the upside move.

Top Updated Crypto News

Cracks in Solana’s (SOL) Chart: Is a Sub-$80 Move the Next Chapter?

TagsAltcoinCryptocurrencyINJInjective

Related Questions

QWhat is the current market sentiment for Injective (INJ) according to the RSI indicator?

AThe Relative Strength Index (RSI) is at 58.50, indicating a mild to moderate bullish sentiment.

QWhat was the percentage increase in Injective's daily trading volume?

AThe daily trading volume skyrocketed by over 525%.

QWhich two key technical indicators are mentioned as being above the zero line, suggesting a bullish trend for INJ?

ABoth the Moving Average Convergence Divergence (MACD) line and the signal line are above the zero line.

QWhat does the Chaikin Money Flow (CMF) value of -0.16 suggest about the INJ market?

AA CMF value of -0.16 suggests moderate selling pressure and indicates that money outflow is stronger, reflecting distribution rather than accumulation.

QWhat are the potential support and resistance levels mentioned for Injective's price?

AThe potential resistance level is at $3.32, and the immediate support level is around $3.12, with a further support zone at $3.01.

Related Reads

Anthropic's IPO Launch: Commercial Miracle or Valuation Bubble?

Anthropic has confidentially filed for an IPO, led by Morgan Stanley and Goldman Sachs, potentially going public by October. Following its latest $650 billion funding round, its pre-IPO valuation stands at $965 billion, with projections reaching up to $2 trillion at listing, which would make it the highest-valued private company ever. The article, written by Fu Sheng, addresses skepticism that this represents an AI bubble akin to the 2000 dot-com crash. It argues the current situation differs fundamentally. Unlike the internet bubble era, which relied on speculative narratives with little revenue, Anthropic's valuation is backed by unprecedented, measurable financial performance. Key data points include: * **Revenue Growth:** ARR skyrocketed from $10 billion in early 2025 to $470 billion by May 2026, targeting $100 billion by year-end—a growth curve unmatched in business history. * **Profitability:** It achieved operating profitability in Q2 2026 with an estimated $5.6 billion profit. * **Efficiency:** With ~3,000 employees and ~$470 billion ARR, its revenue per employee exceeds $10 million. Products like Claude Code, launched less than a year ago, already generate $25 billion in annualized revenue. * **Enterprise Adoption:** It boasts a strong enterprise client base, with 8 of the Fortune 10 and over 1,000 large firms spending over $1 million annually on Claude. The valuation is framed using a traditional SaaS model (e.g., a 10x Price-to-Sales multiple on $100 billion revenue). The author contends the core question for analysts has shifted from "How big could this be?" to "How much is it earning and will earn next quarter?" The discussion extends beyond Anthropic to a broader paradigm shift: the transition from a "carbon-based" to a "silicon-based" economy. Companies are increasingly prioritizing investment in compute and AI capabilities over human resources, as these directly scale productivity and competitive advantage. Anthropic's IPO is thus positioned not just as a corporate milestone, but as a price anchor for this new economic era.

链捕手2h ago

Anthropic's IPO Launch: Commercial Miracle or Valuation Bubble?

链捕手2h ago

Near Returns to the AI Stage: Transformation into a Public Chain Due to 'Payroll Difficulties,' Agent and Privacy Emerge as New Growth Narratives

NEAR Returns to AI Origins: From Payroll Struggles to Blockchain, Now Focusing on AI Agents and Privacy NEAR Protocol's journey began not with grand blockchain ambitions, but from a practical hurdle: its AI startup founders, including Transformer paper co-author Illia Polosukhin, couldn't efficiently pay international developers in 2017. This led them to pivot and build a high-performance, scalable blockchain. After years navigating various crypto narratives like sharding and cross-chain interoperability, NEAR is now leveraging its AI roots to re-enter the AI arena. A key driver is its "NEAR Intents" layer, which abstracts complex cross-chain transactions. Users simply state their goal (e.g., swap BTC for ETH), and a solver network finds the optimal route. This system has processed over $20B in cross-chain volume, generating significant fee revenue. A major growth area is private transactions via "Confidential Intents/Swaps," which hide trade details until settlement to protect against MEV and front-running. Remarkably, private swaps recently accounted for over 40% of NEAR's transaction volume, highlighting strong demand but also potential regulatory scrutiny. With its AI-founder pedigree, NEAR is positioning itself at the intersection of blockchain, AI agents, and privacy, aiming to become infrastructure for the emerging agent economy while navigating the challenges of its rapid adoption.

marsbit5h ago

Near Returns to the AI Stage: Transformation into a Public Chain Due to 'Payroll Difficulties,' Agent and Privacy Emerge as New Growth Narratives

marsbit5h ago

Trading

Spot
Futures

Hot Articles

How to Buy INJ

Welcome to HTX.com! We've made purchasing Injective (INJ) simple and convenient. Follow our step-by-step guide to embark on your crypto journey.Step 1: Create Your HTX AccountUse your email or phone number to sign up for a free account on HTX. Experience a hassle-free registration journey and unlock all features.Get My AccountStep 2: Go to Buy Crypto and Choose Your Payment MethodCredit/Debit Card: Use your Visa or Mastercard to buy Injective (INJ) instantly.Balance: Use funds from your HTX account balance to trade seamlessly.Third Parties: We've added popular payment methods such as Google Pay and Apple Pay to enhance convenience.P2P: Trade directly with other users on HTX.Over-the-Counter (OTC): We offer tailor-made services and competitive exchange rates for traders.Step 3: Store Your Injective (INJ)After purchasing your Injective (INJ), store it in your HTX account. Alternatively, you can send it elsewhere via blockchain transfer or use it to trade other cryptocurrencies.Step 4: Trade Injective (INJ)Easily trade Injective (INJ) on HTX's spot market. Simply access your account, select your trading pair, execute your trades, and monitor in real-time. We offer a user-friendly experience for both beginners and seasoned traders.

2.3k Total ViewsPublished 2024.03.29Updated 2026.06.02

How to Buy INJ

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of INJ (INJ) are presented below.

活动图片